SYNTHASIL APTT REAGENT

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

Under normal conditions of use, the mixture does not cause adverse effects to humans and to the environment. Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet

Other hazards which do not result in classification

The mixture does not meet the criteria for PBT or vPvB. Mixture does not contain substance (s) classified as PBT or vPvB in concentrations above 0,1%. Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Not classified Adverse physicochemical, human health and environmental effects Under normal conditions of use, the mixture does not cause adverse effects to humans and to the environment. Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] No labelling applicable 2.3. Other hazards Other hazards which do not result in classification : The mixture does not meet the criteria for PBT or vPvB. Mixture does not contain substance (s) classified as PBT or vPvB in concentrations above 0,1%. Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % SECTION 3: Composition/information on ingredients 3.1. Substances Not applicable 3.2. Mixtures Comments : Composition: liquid containing organic and inorganic components. Name Product identifier Conc. % Classification according to Regulation (EC) No. w/w 1272/2008 [CLP] 1,2-dibromo-2,4-dicyanobutane CAS-No.: 35691-65-7 < 0.1 Acute Tox. 4 (Oral), H302 (ATE=515 mg/kg bodyweight) EC-No.: 252-681-0 Skin Irrit. 2, H315 Eye Dam. 1, H318 Skin Sens. 1, H317 STOT SE 3, H335 Aquatic Acute 1, H400 (M=1) Aquatic Chronic 1, H410 (M=1) Silicon dioxide (amorphous) CAS-No.: 7631-86-9 (Silica) < 0.03 Not classified EC-No.: 231-545-4 EC Index-No.: not listed in the Annex VI REACH-no: 01-2119379499-16 Silica crystalline - quartz CAS-No.: 14808-60-7 < 0.00004 Carc. 1A, H350i EC-No.: 238-878-4 STOT RE 1, H372 Full text of H- and EUH-statements: see section 16 SECTION 4: First aid measures 4.1. Description of first aid measures First-aid measures after inhalation : If inhaled, move person to fresh air. If breathing is difficult, oxygen should be administered. Get medical advice if adverse symptoms appear. First-aid measures after skin contact : Remove contaminated clothes and shoes. Wash immediately affected area with soap or mild detergent and plenty of water until the removal of the mixture (15-20 minutes). Get medical advice if adverse symptoms appear. First-aid measures after eye contact : Wash immediately with plenty of water or normal saline for at least 15 minutes. Keep eyelid